{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T18:28:26Z","timestamp":1775413706403,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007313","name":"UT | University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["Lung Cancer Moon Shot"],"award-info":[{"award-number":["Lung Cancer Moon Shot"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"UT | University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["Institutional Research Grant"],"award-info":[{"award-number":["Institutional Research Grant"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Waun Ki Hong Lung Cancer Research Fund Exon 20 Group Rexanna\u2019s Foundation for Fighting Lung Cancer"},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP190208"],"award-info":[{"award-number":["RP190208"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5P30CA142543"],"award-info":[{"award-number":["5P30CA142543"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA258584"],"award-info":[{"award-number":["R01CA258584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-021-00383-2","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T16:43:47Z","timestamp":1632415427000},"page":"864-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":263,"title":["Deep learning-based prediction of the T cell receptor\u2013antigen binding specificity"],"prefix":"10.1038","volume":"3","author":[{"given":"Tianshi","family":"Lu","sequence":"first","affiliation":[]},{"given":"Ze","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"James","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Yunguan","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Peixin","family":"Jiang","sequence":"additional","affiliation":[]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[]},{"given":"Chantale","family":"Bernatchez","sequence":"additional","affiliation":[]},{"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-3094","authenticated-orcid":false,"given":"Don L.","family":"Gibbons","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4510-0382","authenticated-orcid":false,"given":"Alexandre","family":"Reuben","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4355-149X","authenticated-orcid":false,"given":"Tao","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"383_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn, G. P., Old, L. J. & Schreiber, R. D. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329\u2013360 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"383_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2015.01.011","volume":"2","author":"PA Ascierto","year":"2015","unstructured":"Ascierto, P. A. & Marincola, F. M. 2015: The year of anti-PD-1\/PD-L1s against melanoma and beyond. EBioMedicine 2, 92\u201393 (2015).","journal-title":"EBioMedicine"},{"key":"383_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","volume":"7","author":"V Anagnostou","year":"2017","unstructured":"Anagnostou, V. et al. Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer. Cancer Discov. 7, 264\u2013276 (2017).","journal-title":"Cancer Discov."},{"key":"383_CR4","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck, M. et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N. Engl. J. Med. 375, 1823\u20131833 (2016).","journal-title":"N. Engl. J. Med."},{"key":"383_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"383_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69\u201374 (2015).","journal-title":"Science"},{"key":"383_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.molmed.2017.08.007","volume":"23","author":"GP Linette","year":"2017","unstructured":"Linette, G. P. & Carreno, B. M. Neoantigen vaccines pass the immunogenicity test. Trends Mol. Med. 23, 869\u2013871 (2017).","journal-title":"Trends Mol. Med."},{"key":"383_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature18945","volume":"536","author":"EME Verdegaal","year":"2016","unstructured":"Verdegaal, E. M. E. et al. Neoantigen landscape dynamics during human melanoma\u2013T cell interactions. Nature 536, 91\u201395 (2016).","journal-title":"Nature"},{"key":"383_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94\u201396 (1996).","journal-title":"Science"},{"key":"383_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nbt.4282","volume":"36","author":"S-Q Zhang","year":"2018","unstructured":"Zhang, S.-Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. 36, 1156\u20131159 (2018).","journal-title":"Nat. Biotechnol."},{"key":"383_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","volume":"178","author":"T Kula","year":"2019","unstructured":"Kula, T. et al. T-Scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016\u20131028.e13 (2019).","journal-title":"Cell"},{"key":"383_CR12","doi-asserted-by":"publisher","unstructured":"Ito, A. et al. Cancer neoantigens: a promising source of immunogens for cancer immunotherapy. J. Clin. Cell. Immunol. https:\/\/doi.org\/10.4172\/2155-9899.1000322 (2015).","DOI":"10.4172\/2155-9899.1000322"},{"key":"383_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1159\/000445656","volume":"39","author":"X Hou","year":"2016","unstructured":"Hou, X. et al. Analysis of the repertoire features of TCR beta chain CDR3 in human by high-throughput sequencing. Cell. Physiol. Biochem. 39, 651\u2013667 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"383_CR14","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1073\/pnas.0408677102","volume":"102","author":"WR Atchley","year":"2005","unstructured":"Atchley, W. R., Zhao, J., Fernandes, A. D. & Dr\u00fcke, T. Solving the protein sequence metric problem. Proc. Natl Acad. Sci. USA 102, 6395\u20136400 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"383_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41592-020-01020-3","volume":"18","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z., Xiong, D., Wang, X., Liu, H. & Wang, T. Mapping the functional landscape of T cell receptor repertoires by single-T cell transcriptomics. Nat. Methods 18, 92\u201399 (2021).","journal-title":"Nat. Methods"},{"key":"383_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0288-x","volume":"8","author":"M Nielsen","year":"2016","unstructured":"Nielsen, M. & Andreatta, M. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Genome Med. 8, 33 (2016).","journal-title":"Genome Med."},{"key":"383_CR17","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/bioinformatics\/btx286","volume":"33","author":"N Tickotsky","year":"2017","unstructured":"Tickotsky, N., Sagiv, T., Prilusky, J., Shifrut, E. & Friedman, N. McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics 33, 2924\u20132929 (2017).","journal-title":"Bioinformatics"},{"key":"383_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"},{"key":"383_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4049\/jimmunol.1801401","volume":"202","author":"A Huth","year":"2019","unstructured":"Huth, A., Liang, X., Krebs, S., Blum, H. & Moosmann, A. Antigen-specific TCR signatures of cytomegalovirus infection. J. Immunol. 202, 979\u2013990 (2019).","journal-title":"J. Immunol."},{"key":"383_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.03.072","volume":"19","author":"G Chen","year":"2017","unstructured":"Chen, G. et al. Sequence and structural analyses reveal distinct and highly diverse human CD8+ TCR repertoires to immunodominant viral antigens. Cell Rep. 19, 569\u2013583 (2017).","journal-title":"Cell Rep."},{"key":"383_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41592-018-0304-8","volume":"16","author":"AV Joglekar","year":"2019","unstructured":"Joglekar, A. V. et al. T cell antigen discovery via signaling and antigen-presenting bifunctional receptors. Nat. Methods 16, 191\u2013198 (2019).","journal-title":"Nat. Methods"},{"key":"383_CR22","doi-asserted-by":"publisher","first-page":"D1057","DOI":"10.1093\/nar\/gkz874","volume":"48","author":"DV Bagaev","year":"2020","unstructured":"Bagaev, D. V. et al. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium. Nucl. Acids Res. 48, D1057\u2013D1062 (2020).","journal-title":"Nucl. Acids Res."},{"key":"383_CR23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/bioinformatics\/btz614","volume":"36","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. PIRD: pan immune repertoire database. Bioinformatics 36, 897\u2013903 (2020).","journal-title":"Bioinformatics"},{"key":"383_CR24","doi-asserted-by":"crossref","unstructured":"Jokinen, E., Heinonen, M., Huuhtanen, J., Mustjoki, S. & L\u00e4hdesm\u00e4ki, H. TCRGP: determining epitope specificity of T cell receptors. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/542332v1 (2019).","DOI":"10.1101\/542332"},{"key":"383_CR25","doi-asserted-by":"crossref","unstructured":"Jurtz, V. I. et al. NetTCR: sequence-based prediction of TCR binding to peptide\u2013MHC complexes using convolutional neural networks. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/433706v1 (2018).","DOI":"10.1101\/433706"},{"key":"383_CR26","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.3389\/fimmu.2019.02820","volume":"10","author":"S Gielis","year":"2019","unstructured":"Gielis, S. et al. Detection of enriched T cell epitope specificity in full T cell receptor sequence repertoires. Front. Immunol. 10, 2820 (2019).","journal-title":"Front. Immunol."},{"key":"383_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2017.11.043","volume":"172","author":"MH Gee","year":"2018","unstructured":"Gee, M. H. et al. Antigen identification for orphan T Cell receptors expressed on tumor-infiltrating lymphocytes. Cell 172, 549\u2013563.e16 (2018).","journal-title":"Cell"},{"key":"383_CR28","doi-asserted-by":"publisher","first-page":"15442","DOI":"10.1074\/jbc.M112.447185","volume":"288","author":"YC Liu","year":"2013","unstructured":"Liu, Y. C. et al. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. J. Biol. Chem. 288, 15442\u201315454 (2013).","journal-title":"J. Biol. Chem."},{"key":"383_CR29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1074\/jbc.M113.522110","volume":"289","author":"DK Cole","year":"2014","unstructured":"Cole, D. K. et al. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR\u2013major histocompatibility complex interactions. J. Biol. Chem. 289, 628\u2013638 (2014).","journal-title":"J. Biol. Chem."},{"key":"383_CR30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aad1253","volume":"350","author":"E Tran","year":"2015","unstructured":"Tran, E. et al. Immunogenicity of somatic mutations in human gastrointestinal cancers. Science 350, 1387\u20131390 (2015).","journal-title":"Science"},{"key":"383_CR31","doi-asserted-by":"publisher","first-page":"8950","DOI":"10.1073\/pnas.160252097","volume":"97","author":"GA Weiss","year":"2000","unstructured":"Weiss, G. A., Watanabe, C. K., Zhong, A., Goddard, A. & Sidhu, S. S. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Proc. Natl Acad. Sci. USA 97, 8950\u20138954 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"383_CR32","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1073\/pnas.1603106113","volume":"113","author":"SA Valkenburg","year":"2016","unstructured":"Valkenburg, S. A. et al. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses. Proc. Natl Acad. Sci. USA 113, 4440\u20134445 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"383_CR33","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/2159-8290.CD-17-1246","volume":"8","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. An empirical approach leveraging tumorgrafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors. Cancer Discov. 8, 1142\u20131155 (2018).","journal-title":"Cancer Discov."},{"key":"383_CR34","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543\u2013550 (2014).","DOI":"10.1038\/nature13385"},{"key":"383_CR35","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519\u2013525 (2012).","DOI":"10.1038\/nature11404"},{"key":"383_CR36","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43\u201349 (2013).","DOI":"10.1038\/nature12222"},{"key":"383_CR37","unstructured":"Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell 161, 1681\u20131696 (2015)."},{"key":"383_CR38","doi-asserted-by":"publisher","first-page":"14003","DOI":"10.1038\/mto.2014.3","volume":"1","author":"AS-Y Lo","year":"2014","unstructured":"Lo, A. S.-Y., Xu, C., Murakami, A. & Marasco, W. A. Regression of established renal cell carcinoma in nude mice using lentivirus-transduced human T cells expressing a human anti-CAIX chimeric antigen receptor. Mol. Ther. Oncolytics 1, 14003 (2014).","journal-title":"Mol. Ther. Oncolytics"},{"key":"383_CR39","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1158\/0008-5472.CAN-15-3139","volume":"76","author":"E Cherkasova","year":"2016","unstructured":"Cherkasova, E. et al. Detection of an immunogenic HERV-E envelope with selective expression in clear cell kidney cancer. Cancer Res. 76, 2177\u20132185 (2016).","journal-title":"Cancer Res."},{"key":"383_CR40","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/2159-8290.CD-17-0256","volume":"7","author":"A Reuben","year":"2017","unstructured":"Reuben, A. et al. TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence. Cancer Discov. 7, 1088\u20131097 (2017).","journal-title":"Cancer Discov."},{"key":"383_CR41","doi-asserted-by":"publisher","first-page":"eaaz3199","DOI":"10.1126\/sciimmunol.aaz3199","volume":"5","author":"T Lu","year":"2020","unstructured":"Lu, T. et al. Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes. Sci. Immunol. 5, eaaz3199 (2020).","journal-title":"Sci. Immunol."},{"key":"383_CR42","doi-asserted-by":"publisher","first-page":"e1644110","DOI":"10.1080\/2162402X.2019.1644110","volume":"8","author":"D Simnica","year":"2019","unstructured":"Simnica, D. et al. T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors. Oncoimmunology 8, e1644110 (2019).","journal-title":"Oncoimmunology"},{"key":"383_CR43","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat. Med. 25, 1916\u20131927 (2019).","journal-title":"Nat. Med."},{"key":"383_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211 (2015).","journal-title":"Science"},{"key":"383_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165, 35\u201344 (2016).","journal-title":"Cell"},{"key":"383_CR46","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim, S. T. et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat. Med. 24, 1449\u20131458 (2018).","journal-title":"Nat. Med."},{"key":"383_CR47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.aan5951","volume":"359","author":"D Miao","year":"2018","unstructured":"Miao, D. et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science 359, 801\u2013806 (2018).","journal-title":"Science"},{"key":"383_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature22383","volume":"547","author":"P Dash","year":"2017","unstructured":"Dash, P. et al. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547, 89\u201393 (2017).","journal-title":"Nature"},{"key":"383_CR49","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"383_CR50","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","volume":"2","author":"M Nielsen","year":"2007","unstructured":"Nielsen, M. et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2, e796 (2007).","journal-title":"PLoS ONE"},{"key":"383_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2105-10-48","volume":"10","author":"E Eden","year":"2009","unstructured":"Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10, 48 (2009).","journal-title":"BMC Bioinformatics"},{"key":"383_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"383_CR53","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat. Med. 25, 1916\u20131927 (2019).","journal-title":"Nat. Med."},{"key":"383_CR54","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.aan5951","volume":"359","author":"D Miao","year":"2018","unstructured":"Miao, D. et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science 359, 801\u2013806 (2018).","journal-title":"Science"},{"key":"383_CR55","doi-asserted-by":"publisher","unstructured":"tianshilu\/pMTnet: First Release (Zenodo, 2021); https:\/\/doi.org\/10.5281\/zenodo.4670312","DOI":"10.5281\/zenodo.4670312"},{"key":"383_CR56","doi-asserted-by":"publisher","unstructured":"jcao89757\/HERVranger: HERVranger (Zenodo, 2021); https:\/\/doi.org\/10.5281\/zenodo.4681560","DOI":"10.5281\/zenodo.4681560"},{"key":"383_CR57","doi-asserted-by":"publisher","unstructured":"tianshilu\/QBRC-Somatic-Pipeline: First Release (Zenodo, 2021); https:\/\/doi.org\/10.5281\/zenodo.4670314","DOI":"10.5281\/zenodo.4670314"},{"key":"383_CR58","doi-asserted-by":"publisher","unstructured":"tianshilu\/QBRC-Neoantigen-Pipeline: First Release (Zenodo, 2021); https:\/\/doi.org\/10.5281\/zenodo.4670320","DOI":"10.5281\/zenodo.4670320"}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00383-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00383-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00383-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T08:22:56Z","timestamp":1699518176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00383-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1038\/s42256-021-00383-2","relation":{},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We are applying for formal intellectual property protection on the pMTnet model and software. A.R. serves on the Scientific Advisory Board and has received honoraria from Adaptive Biotechnologies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}